The Medicines Manufacturing Industry Partnership (MMIP) was established during 2014 to bring the UK’s medicines manufacturing industry together to create an attractive and innovation-rich environment to drive UK competitiveness, and build international recognition, in medicines manufacturing. The MMIP is supported by the Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA), alongside the Knowledge Transfer Network (KTN), and includes senior leadership from GlaxoSmithKline, Pfizer, AstraZeneca, Actavis Biologics, Eisai, FUJIFILM Diosynth Biotechnologies and ReNeuron. The UK’s medicines industry is one of our leading manufacturing sectors, with exports worth £24bn and generating a trade surplus of £5bn in 2013. MMIP wants to ensure that the UK continues to be an attractive place for this high- value industry.